NAMI
PBYI icon

Nomura Asset Management International’s Puma Biotechnology PBYI Stock Holding History

Nomura Asset Management International’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497K Hold
61,255
– – ﹤0.01% 1266
2026
Q1 		$391K Hold
61,255
– – ﹤0.01% 1190
2025
Q4 		$364K Buy
+61,255
New +$325K ﹤0.01% 1195

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nomura Asset Management International's PBYI Position: Q2 2026 in Review

Nomura Asset Management International held its Puma Biotechnology (PBYI) position steady in Q2 2026 at 61,255 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Nomura Asset Management International first reported a position in PBYI in Q4 2025 and has held it in 3 quarters since. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Nomura Asset Management International held 61,255 shares of Puma Biotechnology worth $497K as of Q2 2026.
  • Nomura Asset Management International left its Puma Biotechnology share count unchanged in Q2 2026.
  • Puma Biotechnology made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1266 holding.
  • Nomura Asset Management International first reported a position in Puma Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.